.png)
The US Food and Drug Administration (FDA) has approved the B-cell depleting agent inebilizumab-cdon (Uplizna, Amgen) for the treatment of immunoglobulin G4-related disease (IgG4-RD). This is the first and only treatment approved for this rare autoimmune disease in the United States. An estimated 200,000 people in the United States are living with IgG4-RD...
2931 Ridge Road Ste 101-1020 Rockwall, Texas 75032
+012 345 67890
LeadershipLending@gmail.com
Copyright © 2023 locksmith. All Rights Reserved
